Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 13, 2019
Vitruvias has entered into a collaborative development agreement with Bright Future Pharmaceutical Lab to develop a portfolio of semi-solids to be marketed in the United States and China.
read more
Sunny Pharmtech Inc., a Taiwan-based API and finished-dose drug development company, and Vitruvias Therapeutics, a generic drug development company, have signed two additional agreements to co-develop and market two additional high-value generic ...
read more
VIVEbiotech announced the addition of its 15th in vivo lentiviral vector-based therapeutic program using its well-established platform.
read more
Wednesday, December 04, 2019
Vivera Pharmaceuticals has signed an agreement with Parexel.
read more
Vivli has collaborated with BlueMetal to build a data sharing platform for clinical trial research, powered by Microsoft Azure.
read more
Monday, December 14, 2020
ERS Genomics announced a non-exclusive license agreement granting Vivlion access to ERS Genomics’ CRISPR/Cas9 patent portfolio, to enhance Vivlion’s gene editing reagents and screening services.
read more
Thursday, November 08, 2018
MMS Holdings announced that the company has successfully assisted Vivozon in achieving a Fast Track Designation from the FDA for VVZ-149, a non-opioid pain killer.
read more
Wednesday, November 16, 2022
Viz.ai, a provider of AI-powered disease detection and intelligent care coordination, announced a strategic partnership with Vastrax, a full-service, vascular clinical research organization (CRO).
read more
Viz.ai, a provider of AI-powered disease detection and intelligent care coordination, announced a De Novo approval by the FDA for its Viz HCM module, a hypertrophic cardiomyopathy (HCM) artificial intelligence (AI) detection algorithm, creating a new...
read more
Wednesday, February 13, 2019
Vizient announces it will create a centralized item master tool for a supply chain innovation program envisioned by the Captis network of member hospitals and providers.
read more
Wednesday, January 06, 2016
Voisin Consulting Life Sciences, a global healthcare product development consultancy, and iQone Healthcare, a specialty pharmaceutical company focused on pharmaceutical distribution, sales, marketing and contract services in Europe, have announced a ...
read more
VolitionRx has opened its new research and development facility in Belgium.
read more
Wednesday, December 05, 2018
Voyager Therapeutics, a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, has entered into collaborations with Brammer Bio (Brammer) and Fujifilm Diosynth Biotechnologies (Fujifilm) ...
read more
VTT has started work on a new testing method based on detection of viral antigens for the COVID-19-virus.
read more
Tuesday, December 29, 2020
vTv Therapeutics has entered into a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971.
read more